TAVI (Transcatheter aortic valve implantation)

Rapid-fire abstracts: session 2

27 Nov 2022 – From PCR London Valves 2022

Take advantage of this PCR LV 2022 session to discover more abstracts and learn more about how to predict TAVI bicuspid aortic valve re-access, or right ventricle-pulmonary artery coupling in patients with severe aortic stenosis, among others.

TRISCEND, ACURATE neo2, the LuX-Valve System: Top Late-Breaking Trials from PCR London Vaves 2022

27 Nov 2022 – From PCR London Valves 2022

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions and learn more about the latest evidence evidence concerning new transcatheter valve devices, emerging innovative devices as well as highlighted content from the EuroIntervention journal.

Rapid-fire abstracts: session 3

27 Nov 2022 – From PCR London Valves 2022

Everything you need to know about the OPERA-TAVI registry, the UK TAVI registry, the TAVI-COMIC study, or the external validation of the TRI-SCORE in patients undergoing isolated tricuspid valve surgery, among others, can be found in this session of PCR LV 2022.

TAVI: vascular access and bleeding complications

27 Nov 2022 – From PCR London Valves 2022

To learn more about FAST ACCESS Pilot, transfemoral-only TAVI, next-generation suture-mediated closure device in TAVR, or percutaneous axillary TAVI under local anaesthesia, among others, watch this session from PCR LV 2022!

TAVI: vascular access and bleeding complications

Paravalvular leak closure

27 Nov 2022 – From PCR London Valves 2022

5 specific cases are proposed in this PCR LV 2022 session dedicated to PVL, including concomitant ViV TAVI and paravalvular leak closure, transapical mitral paravalvular leak closure in a young patient, or transcatheter mitral ViV implantation for paravalvular leak. Watch the videos now to find out more!

Tricuspid and pulmonary interventions

27 Nov 2022 – From PCR London Valves 2022

Watch this series of cases presented at PCR LV 2022 and learn more about Alagille syndrome, how to treat a significant right-to-left shunt after bicaval valve implantation, or analyze transcatheter pulmonary valve implantation in tetralogy of Fallot, among others.

TAVI: Late-Breaking Trials and Innovations

27 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions, and learn more about the early safety and performance of the Vienna TAVI system, the new-generation transcatheter aortic valve platforms performance in native pure aortic regurgitation, and more!

TAVI: Late-Breaking Trials and Innovations

Rapid-fire abstracts: session 4

27 Nov 2022 – From PCR London Valves 2022

In this PCR LV 2022 session dedicated to TAVI, take advantage of the 7 abstracts to learn more about the impact of TAVI for pure regurgitation on the severity of concomitant mitral regurgitation, the deformation of transcatheter heart valve and haemodynamics after aortic ViV, and much...

DurAVR THV: Impact of Novel Leaflet Design on Hemodynamics & Transvalvular Physiology – FIH Results

Follow this dialogue between Bernard Prendergast, Christopher Meduri and João Cavalcante where they reflect on the journey in relation to transcatheter aortic valve implantation over the last 20 years and advances that can take us to a very bright and optimistic future - recorded for PCR...

The unmet need in severe aortic regurgitation: are we ready for TAVI?

The prevalence of valvular heart disease increases with advanced age and unfortunately, in many patients, it’s underdiagnosed, especially aortic regurgitation. In this presentation recorded for PCR London Valves 2022, Tanja Rudolph raises the question: are we ready for TAVR in aortic regurgitation?

View more videos and course...

The unmet need in severe aortic regurgitation: are we ready for TAVI?

A patient with severe aortic stenosis – how should I treat concomitant coronary artery disease?

31 Oct 2022

Discover the replay of this PCR Webinar on the Road in Verona, Italy on aortic stenosis with D. Milasinovic, C. de Biase and F. Ribichini.

A patient with severe aortic stenosis – how should I treat concomitant coronary artery disease?

A patient undergoing TAVI - how should I achieve optimal coronary access?

31 Oct 2022

Our duo of hosts Dejan Milasinovic and Chiara de Biase visit the cathlab of Khaled Al-Shaibi, based in Jeddah, Saudi Arabia.

A patient undergoing TAVI- how should we achieve optimal coronary access?

Bicuspid prevalence in China

31 Oct 2022

Discover the replay of this PCR webinar on TAVI with M. Chen, J. Kempfert, J.Z. Junjie, Y. Tang and Y. Wang.

TAVI patients’ Lifetime Management: the unspoken consequences of Permanent Pacemaker Implantation

31 Oct 2022

Watch the replay of this webinar on TAVI with J. Rodés-Cabau, F. Saia and M. Ziacchi

TAVI patients’ Lifetime Management: the unspoken consequences of Permanent Pacemaker Implantation

Balloon- vs self-expanding valve systems for failed small surgical aortic valve bioprostheses

26 Oct 2022

Edoardo provides us with the cardiac surgeon's point of view!

The present trial aimed to clarify the hemodynamic results between balloon-expandable valve (BEV) (SAPIEN 3 ULTRA - Edwards) and self-expandable valve (SEV) (EVOLUT R/Pro/Pro+ - Medtronic) in case of dysfunctional small-sized surgical bio-prosthesis.

Reviewer

Edoardo Zancanaro

Balloon- vs self-expanding valve systems for failed small surgical aortic valve bioprostheses

Porcelain aorta, calcified aortic valve, and calcified left main: what comes first, the valve or the artery?

08 Nov 2022

How would you treat this 76-year-old male patient with severe AS symptomatic for angina, sinus rhythm with RBBB, previous bilateral CEA, and total occlusion of both the left CCA and the subclavian?